Cryptos: 30,452 Exchanges: 348 Market Cap: $2,624.08B 24h Vol: $70.66B Dominance: BTC 50.6% ETH 15.5% ETH Gas:  4 Gwei
Seclect Currency

Fiat currencies

    Crypto Currencies

      No results for ""

      We couldn't find anything matching your search.Try again with a different term.

      OneMedNet's Logo

      OneMedNet - Private

      Overview Investors Company Profile / Project Introduction

      Overview

      Funding Date

      July 26, 2024

      Financing amount

      $4.6M

      Valuation

      --

      Catagory

      Others

      Subcategory

      --

      About OneMedNet - Private

      OneMedNet has announced the completion of a securities purchase agreement with certain institutional investors. These investors include affiliates of Off The Chain Capital and Discovery Capital Management. The private placement has raised approximately $4.6 million, after deducting fees and expenses payable by the company. The price per share of the common stock sold in this offering complies with the minimum price requirements set by Nasdaq rules. The company intends to use the net proceeds from the private placement for working capital and general corporate purposes. While awaiting the utilization of these funds, the company has used $1.8 million of the net proceeds to purchase Bitcoin.

      Investors

      InvestorsTypeLocationYear Founded#Portfolio CompaniesEmail AddressSocials
      FundUnited States of America20162--
      UncategorizedUnknown--1--

      Company Profile / Project Introduction

      OneMedNet provides innovative solutions that unlock the significant value contained within the Real-World Data ("RWD") repositories of over 1,400 healthcare system and provider sites that currently comprise its iRWD™ network. OneMedNet's proprietary iRWD™ platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results, and uniquely, medical imaging. Employing its robust iRWD™ platform, the Company securely de-identifies, searches, and curates the clinical data, bringing a wealth of internal and third-party research opportunities to its drug, medical device and imaging/diagnostic AI development customers.

      View More
      *Fundraising Announcement: Click here